Skip to main content
Have a personal or library account? Click to login
Two rare CHST3 missense variants, p.(Cys247Ser) and p.(Leu294Pro), in the homozygous and compound-heterozygous state cause chondrodysplasia with congenital joint dislocations in a consanguineous Syrian kindred Cover

Two rare CHST3 missense variants, p.(Cys247Ser) and p.(Leu294Pro), in the homozygous and compound-heterozygous state cause chondrodysplasia with congenital joint dislocations in a consanguineous Syrian kindred

Open Access
|Oct 2026
Read online

References

  1. Geister, K.A. and S.A. Camper, Advances in Skeletal Dysplasia Genetics. Annu Rev Genomics Hum Genet, 2015. 16: 199–227.
  2. Krakow, D. and D.L. Rimoin, The skeletal dysplasias. Genet Med, 2010. 12(6): 327–41.
  3. Mortier, G.R., et al., Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A, 2019. 179(12): 2393–2419.
  4. Unger, S., et al., Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A, 2023. 191(5): 1164–1209.
  5. Mizumoto, S. and S. Yamada, Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis. Front Genet, 2021. 12: 717535.
  6. Begolli, G., et al., Carbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications. Biochem Med (Zagreb), 2023. 33(3): 030503.
  7. Fukuta, M., et al., Molecular cloning and expression of human chondroitin 6-sulfotransferase. Biochim Biophys Acta, 1998. 1399(1): 57–61.
  8. Negishi, M., et al., Structure and function of sulfotransferases. Arch Biochem Biophys, 2001. 390(2): 149–57.
  9. Uchimura, K., et al., Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem, 2002. 277(2): 1443–50.
  10. Rajab, A., J. Kunze, and S. Mundlos, Spondyloepiphyseal dysplasia Omani type: a new recessive type of SED with progressive spinal involvement. Am J Med Genet A, 2004. 126A(4): 413–9.
  11. Thiele, H., et al., Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci U S A, 2004. 101(27): 10155–60.
  12. Hermanns, P., et al., Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. Am J Hum Genet, 2008. 82(6): 1368–74.
  13. van Roij, M.H., et al., Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype. Am J Med Genet A, 2008. 146A(18): 2376–84.
  14. Tuysuz, B., et al., Omani-type spondyloepiphyseal dysplasia with cardiac involvement caused by a missense mutation in CHST3. Clin Genet, 2009. 75(4): 375–83.
  15. Unger, S., et al., Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features. Am J Med Genet A, 2010. 152A(10): 2543–9.
  16. Superti-Furga, A. and S. Unger, Chondrodysplasia with Congenital Joint Dislocations, CHST3-Related, in GeneReviews((R)), M.P. Adam, et al., Editors. 1993: Seattle (WA).
  17. Otaify, G.A., et al., CHST3-related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum. Am J Med Genet A, 2023. 191(8): 2100–2112.
  18. Singh, S., et al., Indian patients with CHST3-related chondrodysplasia with congenital joint dislocations. Am J Med Genet A, 2024. 194(3): e63422.
  19. Waryah, A.M., et al., A novel CHST3 allele associated with spondyloepiphyseal dysplasia and hearing loss in Pakistani kindred. Clin Genet, 2016. 90(1): 90–5.
  20. Srivastava, P., et al., Spondyloepiphyseal dysplasia Omani type: CHST3 mutation spectrum and phenotypes in three Indian families. Am J Med Genet A, 2017. 173(1): 163–168.
  21. Kausar, M., et al., Biallelic variants in CHST3 cause Spondyloepiphyseal dysplasia with joint dislocations in three Pakistani kindreds. BMC Musculoskelet Disord, 2022. 23(1): 818.
  22. Mughal, T.A., et al., A Novel Missense Variant in the CHST3 Underlies Spondyloepiphyseal Dysplasia with Congenital Joint Dislocations. Mol Syndromol, 2024. 15(5): 355–361.
  23. Pantoja-Melendez, C.A., et al., Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation. PLoS One, 2017. 12(1): e0170280.
  24. Duz, M.B. and A. Topak, Recurrent c.776T>C mutation in CHST3 with four other novel mutations and a literature review. Clin Dysmorphol, 2020. 29(4): 167–172.
  25. Hackl, L., et al., Homozygous DHCR7 p.Val330Met Variant Associated with Mild Non-Syndromic Intellectual Disability and Elevated Serum 7-Dehydrocholesterol Levels in Two Siblings. Genes (Basel), 2025. 16(7).
  26. Gudmundsson, S., et al., Variant interpretation using population databases: Lessons from gnomAD. Hum Mutat, 2022. 43(8): 1012–1030.
  27. Ioannidis, N.M., et al., REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet, 2016. 99(4): 877–885.
  28. Rentzsch, P., et al., CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res, 2019. 47(D1): D886–D894.
  29. Pejaver, V., et al., Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am J Hum Genet, 2022. 109(12): 2163–2177.
  30. Jumper, J., et al., Highly accurate protein structure prediction with AlphaFold. Nature, 2021. 596(7873): 583–589.
  31. Frappier, V., M. Chartier, and R.J. Najmanovich, ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability. Nucleic Acids Res, 2015. 43(W1): W395–400.
  32. Gerasimavicius, L., X. Liu, and J.A. Marsh, Identification of pathogenic missense mutations using protein stability predictors. Sci Rep, 2020. 10(1): 15387.
  33. Richards, S., et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015. 17(5): 405–24.
  34. Tavtigian, S.V., et al., Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum Mutat, 2020. 41(10): 1734–1737.
  35. Liang, H., et al., A Chinese case of CHST3-related skeletal dysplasia and a systematic review. Endocrine, 2023. 80(3): 658–668.
  36. Bittles, A.H. and M.L. Black, Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A, 2010. 107 Suppl 1(Suppl 1): 1779–86.
  37. Richard, I., et al., Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 1995. 81(1): 27–40.
  38. Muys, J., et al., Prenatal homozygosity mapping detects a novel mutation in CHST3 in a fetus with skeletal dysplasia and joint dislocations. Clin Case Rep, 2017. 5(4): 440–445.
  39. Tanteles, G.A., et al., Two Somali half-siblings with CHST3-related chondrodysplasia illustrating the phenotypic spectrum and intrafamilial variability. Am J Med Genet A, 2013. 161A(10): 2588–93.
  40. Yan, W., et al., Novel carbohydrate sulfotransferase 3 mutation causing spondyloepiphyseal dysplasia with congenital joint dislocations in a Chinese family. . Ann Joint 2017. 2(2).
  41. Ranza, E., et al., Chondrodysplasia with multiple dislocations: comprehensive study of a series of 30 cases. Clin Genet, 2017. 91(6): 868–880.
  42. Van Biesen, N., P. Cools, and E. Meyers, Comparison and Optimization of DNA Extraction Methods for Human DNA from Dried Blood Spot Samples. Pediatr Rep, 2025. 17(2).
  43. Jarvik, G.P. and B.L. Browning, Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants. Am J Hum Genet, 2016. 98(6): 1077–1081.
Language: English
Page range: 299 - 312
Published online: Oct 31, 2026
Published in print: Oct 1, 2026
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Julia Vodopiutz, Magdalena Felderer, Gabriel Floriani, Dietmar Rieder, Dorota Garczarczyk-Asim, Thomas Müller, Andreas R Janecke, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.